Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Ch 5132799
2. Ch-5132799
3. Ch5132799
1. Ch5132799
2. 1007207-67-1
3. Ch-5132799
4. Ch 5132799
5. Izorlisib
6. Chembl1684984
7. Ch5132799 (pa-799)
8. Jcl936w835
9. Pa799
10. Pa-799
11. 5-(7-methanesulfonyl-2-morpholin-4-yl-6,7-dihydro-5h-pyrrolo[2,3-d]pyrimidin-4-yl)-pyrimidin-2-ylamine
12. (5-(7-methylsulfonyl-2-(morpholin-4-yl)-6,7-dihydro-5h-pyrrolo(2,3-d)pyrimidin-4-yl)pyrimidin-2-yl)amine
13. Unii-jcl936w835
14. 5-(7-methylsulfonyl-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl)pyrimidin-2-amine
15. Izorlisib [inn]
16. Mls006010989
17. Gtpl7743
18. Schembl2377154
19. Dtxsid40678540
20. Ex-a997
21. Men1611
22. Hms3656h15
23. Hms3750i19
24. Bcp02894
25. Men-1611
26. Bdbm50338197
27. Mfcd22419020
28. Nsc762382
29. Nsc800984
30. S2699
31. Zinc66074200
32. Akos025404886
33. Bcp9000513
34. Ccg-264982
35. Cs-0981
36. Db13051
37. Nsc-762382
38. Nsc-800984
39. Sb20410
40. Ncgc00346650-01
41. Ncgc00346650-06
42. 5-[7-(methanesulfonyl)-2-(morpholin-4-yl)-6,7-dihydro-5h-pyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine
43. Ac-28422
44. As-16285
45. Hy-15466
46. Smr004702790
47. Bcp0726000261
48. Sw220190-1
49. J-000203
50. Q27075949
51. 2-pyrimidinamine, 5-[6,7-dihydro-7-(methylsulfonyl)-2-(4-morpholinyl)-5h-pyrrolo[2,3-d]pyrimidin-4-yl]-
52. 5-[7-(methylsulfonyl)-2-(morpholin-4-yl)-6,7-dihydro-5h-pyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine
53. 5-[7-methanesulfonyl-2-(morpholin-4-yl)-5h,6h,7h-pyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine
Molecular Weight | 377.4 g/mol |
---|---|
Molecular Formula | C15H19N7O3S |
XLogP3 | -0.6 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 3 |
Exact Mass | 377.12700867 g/mol |
Monoisotopic Mass | 377.12700867 g/mol |
Topological Polar Surface Area | 136 Ų |
Heavy Atom Count | 26 |
Formal Charge | 0 |
Complexity | 587 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
65
PharmaCompass offers a list of MEN1611 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right MEN1611 manufacturer or MEN1611 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred MEN1611 manufacturer or MEN1611 supplier.
PharmaCompass also assists you with knowing the MEN1611 API Price utilized in the formulation of products. MEN1611 API Price is not always fixed or binding as the MEN1611 Price is obtained through a variety of data sources. The MEN1611 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A AKOS025404886 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of AKOS025404886, including repackagers and relabelers. The FDA regulates AKOS025404886 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. AKOS025404886 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A AKOS025404886 supplier is an individual or a company that provides AKOS025404886 active pharmaceutical ingredient (API) or AKOS025404886 finished formulations upon request. The AKOS025404886 suppliers may include AKOS025404886 API manufacturers, exporters, distributors and traders.
AKOS025404886 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of AKOS025404886 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right AKOS025404886 GMP manufacturer or AKOS025404886 GMP API supplier for your needs.
A AKOS025404886 CoA (Certificate of Analysis) is a formal document that attests to AKOS025404886's compliance with AKOS025404886 specifications and serves as a tool for batch-level quality control.
AKOS025404886 CoA mostly includes findings from lab analyses of a specific batch. For each AKOS025404886 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
AKOS025404886 may be tested according to a variety of international standards, such as European Pharmacopoeia (AKOS025404886 EP), AKOS025404886 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (AKOS025404886 USP).